comparemela.com

Latest Breaking News On - Optiva securities - Page 3 : comparemela.com

OKYO Pharma LTD: OKYO Pharma Now Participating on the Webull Corporate Communications Service Platform

Webull's community of active participants can now access OKYO's profile on the leading mobile-first brokerage platformLONDON and NEW YORK, May 11, 2023 (GLOBE NEWSWIRE) OKYO Pharma Limited (LSE: OKYO

London
City-of
United-kingdom
Gabriel-cerrone
Robert-emmet
Paul-spencer
Garys-jacob
Exchange-commission
Webull-advisors
Nasdaq
Pharma-limited
Securities-investor-protection-corporation

OKYO Pharma Announces Presentations at the American Society of Cataract and Refractive Surgery (ASCRS 2023) in San Diego, CA, May 5-8, 2023

LONDON and NEW YORK, May 03, 2023 OKYO Pharma Limited , an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease to address the significant unmet. | May 3, 2023

United-kingdom
San-diego
California
United-states
London
City-of
American
Paul-spencer
Robert-emmet
Garys-jacob
Pedram-hamrah
Nasdaq

vimarsana © 2020. All Rights Reserved.